Cavanaugh Sarah — SEC Form 4 filings

SEC reporting owner CIK 1709113. 4 Form 4 filings on record with FilingPulse; latest filed 2026-06-29.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-06-03 to 2026-06-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Celldex Therapeutics, Inc. (CLDX)SVP OF CORP AFFAIRS & ADMIN.41 leg · 20,853 sh · $703,3347

Form 4 filings — Cavanaugh Sarah

FiledFormIssuerReported transactionsSource
2026-06-294Celldex Therapeutics, Inc. (CLDX)Grant/award (A): 95,000 (derivative) @ $0EDGAR
2025-06-094Celldex Therapeutics, Inc. (CLDX)Grant/award (A): 78,000 (derivative) @ $0EDGAR
2024-06-174Celldex Therapeutics, Inc. (CLDX)Grant/award (A): 78,000 (derivative) @ $0EDGAR
2024-06-034Celldex Therapeutics, Inc. (CLDX)Option exercise (M): 10,750 @ $2.78 · Option exercise (M): 10,103 @ $9.02 · Sale (S): 20,853 @ $33.73 · Option exercise (M): 10,750 (derivative) @ $0 · Option exercise (M): 10,103 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1709113 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →